Evidence that Cd101 is an autoimmune diabetes gene in nonobese diabetic mice

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 325-336

  Rainbow, Daniel B ^a   Moule, Carolyn ^a   Fraser, Heather I ^a   Clark, Jan ^a   Howlett, Sarah K ^a   Burren, Oliver ^a   Christensen, Mikkel ^a   Moody, Val ^a   Steward, Charles A ^b   Mohammed, Javid P ^c   Fusakio, Michael E ^c   Masteller, Emma L ^d,e   Finger, Erik B ^d,e   Houchins, J P ^f   Naf, Dieter ^g   Koentgen, Frank ^g   Ridgway, William M ^h   Todd, John A ^a   Bluestone, Jeffrey A ^d,e   Peterson, Laurence B ^i,k   Mattner, Jochen ^c,j   Wicker, Linda S ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f R and D Systems Inc   (United States)

^g Ozgene Pty Ltd   (Australia)

^h UNIVERSITY OF CINCINNATI   (United States)

ⁱ MERCK RESEARCH LABORATORIES   (United States)

^j UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^k HOFFMANN LA ROCHE INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CD101 GENE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; GENE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; IMMUNOCOMPETENT CELL; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD; AUTOIMMUNE DISEASES; CHO CELLS; CRICETINAE; CRICETULUS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; MICE; MICE, CONGENIC; MICE, INBRED A; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA;

EID: 79960431415     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003523     Document Type: Article

References (32)

1. Penha-Gonçalves, C., C. Moule, L. J. Smink, J. Howson, S. Gregory, J. Rogers, P. A. Lyons, J. J. Suttie, C. J. Lord, L. B. Peterson, et al. 2003. Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice. Diabetes 52: 1551-1556. (Pubitemid 36666213)
2. Bagot, M., I. Martinel, D. Charue, F. Weill, M. L. Boulland, J. Wechsler, G. J. Freeman, A. Bensussan, and L. Boumsell. 1997. CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation. Tissue Antigens 50: 439-448.
3. Fernandez, I., R. Zeiser, H. Karsunky, N. Kambham, A. Beilhack, K. Soderstrom, R. S. Negrin, and E. Engleman. 2007. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J. Immunol. 179: 2808-2814.
4. Rivas, A., C. L. Ruegg, J. Zeitung, R. Laus, R. Warnke, C. Benike, and E. G. Engleman. 1995. V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies. J. Immunol. 154: 4423-4433.
5. Russell, G. J., C. M. Parker, A. Sood, E. Mizoguchi, E. C. Ebert, A. K. Bhan, and M. B. Brenner. 1996. p126 (CDw101), a costimulatory molecule preferentially expressed on mucosal T lymphocytes. J. Immunol. 157: 3366-3374.
6. Mohammed, J. P., M. E. Fusakio, D. B. Rainbow, C. Moule, H. I. Fraser, J. Clark, J. A. Todd, L. B. Peterson, P. B. Savage, M. Wills-Karp, et al. 2011. Identification of Cd101 as a susceptibility gene for Novosphingbobium aromaticivorans-induced liver autoimmunity. J. Immunol. 187: 337-349.
7. Bouloc, A., M. Bagot, S. Delaire, A. Bensussan, and L. Boumsell. 2000. Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production. Eur. J. Immunol. 30: 3132-3139.
8. Soares, L. R., A. Rivas, L. Tsavaler, and E. G. Engleman. 1997. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism. J. Immunol. 159: 1115-1124.
9. Fraser, H. I., C. A. Dendrou, B. Healy, D. B. Rainbow, S. Howlett, L. J. Smink, S. Gregory, C. A. Steward, J. A. Todd, L. B. Peterson, and L. S. Wicker. 2010. Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene. J. Immunol. 184: 5075-5084.
10. Rozen, S., and H. Skaletsky. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132: 365-386.
11. Hughes, E. D., Y. Y. Qu, S. J. Genik, R. H. Lyons, C. D. Pacheco, A. P. Lieberman, L. C. Samuelson, I. O. Nasonkin, S. A. Camper, M. L. Van Keuren, and T. L. Saunders. 2007. Genetic variation in C57BL/6 ES cell lines and genetic instability in the Bruce4 C57BL/6 ES cell line. Mamm. Genome 18: 549-558. (Pubitemid 47497926)
12. Schwenk, F., U. Baron, and K. Rajewsky. 1995. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 23: 5080-5081. (Pubitemid 26012492)
13. Hobbs, S., S. Jitrapakdee, and J. C. Wallace. 1998. Development of a bicistronic vector driven by the human polypeptide chain elongation factor 1a promoter for creation of stable mammalian cell lines that express very high levels of recombinant proteins. Biochem. Biophys. Res. Commun. 252: 368-372.
14. Hulbert, E. M., L. J. Smink, E. C. Adlem, J. E. Allen, D. B. Burdick, O. S. Burren, V. M. Cassen, C. C. Cavnor, G. E. Dolman, D. Flamez, et al. 2007. T1DBase: integration and presentation of complex data for type 1 diabetes research. Nucleic Acids Res. 35(Database issue): D742-D746.
15. Smink, L. J., E. M. Helton, B. C. Healy, C. C. Cavnor, A. C. Lam, D. Flamez, O. S. Burren, Y. Wang, G. E. Dolman, D. B. Burdick, et al. 2005. T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res. 33(Database issue): D544-D549. (Pubitemid 40207933)
16. Stein, L. D., C. Mungall, S. Shu, M. Caudy, M. Mangone, A. Day, E. Nickerson, J. E. Stajich, T. W. Harris, A. Arva, and S. Lewis. 2002. The generic genome browser: a building block for a model organism system database. Genome Res. 12: 1599-1610. (Pubitemid 35175099)
17. Araki, M., D. Chung, S. Liu, D. B. Rainbow, G. Chamberlain, V. Garner, K. M. Hunter, L. Vijayakrishnan, L. B. Peterson, M. Oukka, et al. 2009. Genetic evidence that the differential expression of the ligand-independent isoform of CTLA-4 is the molecular basis of the Idd5.1 type 1 diabetes region in nonobese diabetic mice. J. Immunol. 183: 5146-5157.
18. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337.
19. Ridgway, W. M., B. Healy, L. J. Smink, D. Rainbow, and L. S. Wicker. 2007. New tools for defining the 'genetic background' of inbred mouse strains. Nat. Immunol. 8: 669-673.
20. Wade, C. M., E. J. Kulbokas, III, A. W. Kirby, M. C. Zody, J. C. Mullikin, E. S. Lander, K. Lindblad-Toh, and M. J. Daly. 2002. The mosaic structure of variation in the laboratory mouse genome. Nature 420: 574-578.
21. Wiltshire, T., M. T. Pletcher, S. Batalov, S. W. Barnes, L. M. Tarantino, M. P. Cooke, H. Wu, K. Smylie, A. Santrosyan, N. G. Copeland, et al. 2003. Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc. Natl. Acad. Sci. USA 100: 3380-3385.
22. Kamanaka, M., D. Rainbow, K. Schuster-Gossler, E. E. Eynon, A. V. Chervonsky, L. S. Wicker, and R. A. Flavell. 2009. Amino acid polymorphisms altering the glycosylation of IL-2 do not protect from type 1 diabetes in the NOD mouse. Proc. Natl. Acad. Sci. USA 106: 11236-11240.
23. Lyons, P. A., N. Armitage, C. J. Lord, M. S. Phillips, J. A. Todd, L. B. Peterson, and L. S. Wicker. 2001. Mapping by genetic interaction: high resolution congenic mapping of the type 1 diabetes loci Idd10 and Idd18 in the NOD mouse. Diabetes 50: 2633-2637.
24. Buard, J., and B. de Massy. 2007. Playing hide and seek with mammalian meiotic crossover hotspots. Trends Genet. 23: 301-309. (Pubitemid 46770898)
25. Limaye, N., K. A. Belobrajdic, A. E. Wandstrat, F. Bonhomme, S. V. Edwards, and E. K. Wakeland. 2008. Prevalence and evolutionary origins of autoimmune susceptibility alleles in natural mouse populations. Genes Immun. 9: 61-68.
26. Dendrou, C. A., V. Plagnol, E. Fung, J. H. Yang, K. Downes, J. D. Cooper, S. Nutland, G. Coleman, M. Himsworth, M. Hardy, et al. 2009. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat. Genet. 41: 1011-1015.
27. Irie, J., B. Reck, Y. Wu, L. S. Wicker, S. Howlett, D. Rainbow, E. Feingold, and W. M. Ridgway. 2008. Genome-wide microarray expression analysis of CD4+ T Cells from nonobese diabetic congenic mice identifies Cd55 (Daf1) and Acadl as candidate genes for type 1 diabetes. J. Immunol. 180: 1071-1079.
28. Todd, J. A. 2010. Etiology of type 1 diabetes. Immunity 32: 457-467.
29. Saxena, V., J. K. Ondr, A. F. Magnusen, D. H. Munn, and J. D. Katz. 2007. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol. 179: 5041-5053.
30. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
31. Punkosdy, G. A., M. Blain, D. D. Glass, M. M. Lozano, L. O'Mara, J. P. Dudley, R. Ahmed, and E. M. Shevach. 2011. Regulatory T-cell expansion during chronic viral infection is dependent on endogenous retroviral superantigens. Proc. Natl. Acad. Sci. USA 108: 3677-3682.
32. Sgouroudis, E., A. Albanese, and C. A. Piccirillo. 2008. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice. J. Immunol. 181: 6283-6292.